Hyster-Yale: Stabilizing Bookings, But Recovery Risks Remain Elevated
Hyster-Yale, Inc. faced a difficult first quarter in 2026, reporting a 13% decline in revenue and negative EBITDA. The company is experiencing a $26 million operating loss attributed to tariffs and an unfavorable product mix. While there are signs of stabilization in bookings and backlog, significant recovery risks remain, particularly due to tariff uncertainties and high leverage.
- ▪Hyster-Yale reported a 13% decline in revenue for Q1'26.
- ▪The company experienced a negative EBITDA and a $26 million operating loss.
- ▪Bookings and backlog are showing early signs of stabilization.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Industrial ","item":"https://seekingalpha.com/stock-ideas/industrial-goods"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4906988-hyster-yale-stabilizing-bookings-but-recovery-risks-remain-elevated"},"author":{"@type":"Person","name":"Sandpiper Investment…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.